Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1050 of 1,261
  1. US 7431929

    Use of vaccinia virus deleted for the E3L gene as a vaccine vector

    THE ARIZONA BOARD OF REGENTS · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  2. US 7432349

    Tumor suppressor gene, p28ING5

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  3. CA 2682039

    PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE

    MENARINI FARMA IND [IT] · Granted Oct 2, 2008 · Expires Sep 27, 2028

    granted
  4. US 2008241252

    METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS

    ALLERGAN INC [US] · Granted Oct 2, 2008 · Expires Sep 27, 2028

    granted
  5. US 7429559

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  6. US 7429457

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    The Regents of the University of California · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  7. US 7429596

    1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof

    The Regents of the University of California · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  8. US 7429616

    Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

    The Board of Regents of the University of Texas System · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  9. US 7429571

    Therapeutic furopyrimidines and thienopyrimidines

    BioCryst Pharmaceuticals, Inc. · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  10. US 7429562

    Cyclosporin analog formulations

    Isotechnika, Inc. · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  11. US 7429238

    Systems and methods for the generation of crystalline polymorphs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  12. US 7429387

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  13. US 7429374

    Process for the measurement of the potency of glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  14. US 7429485

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  15. US 7427389

    Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

    Provectus Pharmatech, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  16. US 7427671

    Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  17. US 7427639

    β2-adrenergic receptor agonists

    Theravance, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  18. US 7427602

    Sustained DNA delivery from structural matrices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  19. US 7427590

    Neurothrophic components of the ADNF I complex

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  20. US 7427598

    Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  21. US 7427496

    Anti-cancer compounds

    The Regents of the University of Colorado · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  22. US 7427408

    Quorum sensing and biofilm formation

    The Regents of the University of California · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  23. US 7427630

    Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

    Neurocrine Biosciences, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  24. US 7427394

    Biodegradable poly(β-amino esters) and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.